rs850713

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002087.4(GRN):​c.462+24G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 1,602,776 control chromosomes in the GnomAD database, including 52,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6050 hom., cov: 25)
Exomes 𝑓: 0.25 ( 46445 hom. )

Consequence

GRN
NM_002087.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.981

Publications

19 publications found
Variant links:
Genes affected
GRN (HGNC:4601): (granulin precursor) Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The 88 kDa precursor protein, progranulin, is also called proepithelin and PC cell-derived growth factor. Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6 kDa peptides. These smaller cleavage products are named granulin A, granulin B, granulin C, etc. Epithelins 1 and 2 are synonymous with granulins A and B, respectively. Both the peptides and intact granulin protein regulate cell growth. However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth. Granulin family members are important in normal development, wound healing, and tumorigenesis. [provided by RefSeq, Jul 2008]
GRN Gene-Disease associations (from GenCC):
  • frontotemporal dementia and/or amyotrophic lateral sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • neuronal ceroid lipofuscinosis 11
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-44350364-G-A is Benign according to our data. Variant chr17-44350364-G-A is described in ClinVar as Benign. ClinVar VariationId is 558917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRNNM_002087.4 linkc.462+24G>A intron_variant Intron 5 of 12 ENST00000053867.8 NP_002078.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRNENST00000053867.8 linkc.462+24G>A intron_variant Intron 5 of 12 1 NM_002087.4 ENSP00000053867.2

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
41338
AN:
149572
Hom.:
6049
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.327
Gnomad AMI
AF:
0.176
Gnomad AMR
AF:
0.233
Gnomad ASJ
AF:
0.354
Gnomad EAS
AF:
0.491
Gnomad SAS
AF:
0.323
Gnomad FIN
AF:
0.299
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.276
GnomAD2 exomes
AF:
0.281
AC:
70539
AN:
250930
AF XY:
0.282
show subpopulations
Gnomad AFR exome
AF:
0.338
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.356
Gnomad EAS exome
AF:
0.492
Gnomad FIN exome
AF:
0.306
Gnomad NFE exome
AF:
0.237
Gnomad OTH exome
AF:
0.266
GnomAD4 exome
AF:
0.246
AC:
357114
AN:
1453084
Hom.:
46445
Cov.:
33
AF XY:
0.248
AC XY:
179720
AN XY:
723452
show subpopulations
African (AFR)
AF:
0.318
AC:
10608
AN:
33340
American (AMR)
AF:
0.224
AC:
10007
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.358
AC:
9334
AN:
26078
East Asian (EAS)
AF:
0.505
AC:
20017
AN:
39652
South Asian (SAS)
AF:
0.314
AC:
27022
AN:
86104
European-Finnish (FIN)
AF:
0.301
AC:
16041
AN:
53272
Middle Eastern (MID)
AF:
0.323
AC:
1861
AN:
5754
European-Non Finnish (NFE)
AF:
0.223
AC:
246065
AN:
1104084
Other (OTH)
AF:
0.269
AC:
16159
AN:
60094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
17036
34072
51107
68143
85179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8592
17184
25776
34368
42960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.276
AC:
41346
AN:
149692
Hom.:
6050
Cov.:
25
AF XY:
0.278
AC XY:
20311
AN XY:
72962
show subpopulations
African (AFR)
AF:
0.327
AC:
13264
AN:
40578
American (AMR)
AF:
0.233
AC:
3520
AN:
15106
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
1224
AN:
3456
East Asian (EAS)
AF:
0.490
AC:
2423
AN:
4948
South Asian (SAS)
AF:
0.323
AC:
1515
AN:
4686
European-Finnish (FIN)
AF:
0.299
AC:
3081
AN:
10308
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.230
AC:
15500
AN:
67332
Other (OTH)
AF:
0.276
AC:
574
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1427
2854
4280
5707
7134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.254
Hom.:
963
Bravo
AF:
0.274
Asia WGS
AF:
0.388
AC:
1354
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.9
DANN
Benign
0.68
PhyloP100
-0.98
PromoterAI
0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs850713; hg19: chr17-42427732; COSMIC: COSV50006138; COSMIC: COSV50006138; API